Show simple item record

AuthorEl Hajj, Maguy
AuthorKheir, Nadir
AuthorAl Mulla, Abdullah
AuthorAl-Badriyeh, Daoud
AuthorAl Kaddour, Ahmad
AuthorMahfoud, Ziyad
AuthorSalehi, Mohamed
AuthorFanous, Nadia
Available date2015-12-02T06:15:57Z
Publication Date2015-02-26
Publication NameTrials
CitationEl-Hajj, M. et al. "Assessing the effectiveness of a pharmacist delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial". Trials (2015). Volume 16
ISSN1745-6215
URIhttp://dx.doi.org/10.1186/s13063-015-0570-z
URIhttp://hdl.handle.net/10576/3888
AbstractBackground: It had been reported that up to 37% of the adult male population smokes cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is key to reducing smoking-related diseases and deaths. Healthcare providers are in an ideal position to encourage smoking cessation. Pharmacists are the most accessible healthcare providers and are uniquely situated to initiate behavior change among patients. Many studies have shown that pharmacists can be successful in helping patients quit smoking. Studies demonstrating the effectiveness of pharmacist-delivered smoking cessation programs are lacking in Qatar. This proposal aims to test the effect of a structured smoking cessation program delivered by trained ambulatory pharmacists in Qatar. Methods/Design: A prospective, randomized, controlled trial is conducted at eight ambulatory pharmacies in Qatar. Participants are randomly assigned to receive an at least four-session face-to-face structured patient-specific smoking cessation program conducted by the pharmacist or 5 to 10 min of unstructured brief smoking cessation advice (emulating current practice) given by the pharmacist. Both groups are offered nicotine replacement therapy if feasible. The primary outcome of smoking cessation will be confirmed by an exhaled carbon monoxide test at 12 months. Secondary outcomes constitute quality-of-life adjustment as well as cost analysis of program resources consumed, including per case and patient outcome. Discussion: If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease the smoking burden. Trial registration: Clinical Trials NCT02123329.
SponsorQatar National Research Fund under its National Priorities Research Program (NPRP).
Languageen
PublisherBioMed Central
SubjectQatar
SubjectTobacco control
SubjectSmoking cessation
SubjectPharmacist
TitleAssessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial
TypeArticle
Volume Number16


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record